Clinical Trials Sponsored by NTShub, S.L.

Total 2725 results

Palau Pharma S.A.

Completed

Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge

Seasonal Allergic Rhinitis

Germany
Palau Pharma S.A.

Completed

A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Belgium, Hungary, Slovakia, Spain
S.M. Misericordia Hospital

Completed

Microcirculation Assessment in Diabetes and Metabolic Syndrome (MADAME)

Diabetes | Metabolic Syndrome | Coronary Microvascular Dysfunction

Italy
Igefarma Laboratorios S.A.

Completed

Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate

Acne Vulgaris

Brazil
Janssen-Cilag, S.A.

Completed

A Registry of Treatment Adherence for Patients With Schizophrenia

Psychotic Disorders | Schizophrenia
Addex Pharma S.A.

Terminated

ADX10059 Migraine Prevention Study

Migraine

Germany, Austria, Belgium, France, United Kingdom
Ferrer Internacional S.A.

Completed

Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure. (TORAFIC)

Congestive Heart Failure

Spain
EXO Biologics S.A.

Recruiting

Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants (EVENEW)

Bronchopulmonary Dysplasia

Italy, Belgium
Eurofarma Laboratorios S.A.

Not yet recruiting

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) (TRIPLAR)

Chronic Obstructive Pulmonary Disease

Brazil
Faes Farma, S.A.

Not yet recruiting

Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

Colitis, Ulcerative
Volumina Medical S.A.

Recruiting

Clinical Investigation Evaluating the Safety and Feasibility of Adipearl

Mid-face Volume Deficiency

Sweden
Aileens Pharma SRL

Recruiting

Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis

Atopic Dermatitis

Italy
Eurofarma Laboratorios S.A.

Not yet recruiting

Evaluation of the Protection of a Liquid Bandage

Skin Care

Brazil
Blau Farmaceutica S.A.

Not yet recruiting

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

Breast Cancer
Blau Farmaceutica S.A.

Not yet recruiting

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration

Anticoagulant
Blau Farmaceutica S.A.

Not yet recruiting

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Neoplasms | Anemia | Chemotherapeutic-Induced Anemia
Biozeus Biopharmaceutical S.A.

Recruiting

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Erectile Dysfunction | Prostate Cancer | Radical Prostatectomy | Erectile Dysfunction Following Radical Prostatectomy

Brazil
Oryzon Genomics S.A.

Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+) (FRIDA)

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory

United States
ADC Therapeutics S.A.

Recruiting

A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors

Advanced Solid Tumors

United States, United Kingdom, Spain, France
Eurofarma Laboratorios S.A.

Not yet recruiting

Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment (RESFRIN)

Cold | Flu Symptom

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine

Migraine

Brazil
ADC Therapeutics S.A.

Recruiting

Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (LOTIS 5)

Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma

Japan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
Eurofarma Laboratorios S.A.

Recruiting

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Breast Cancer

Breast Cancer

India
ADC Therapeutics S.A.

Terminated

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Melanoma | Renal Cell Carcinoma | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Pancreas Cancer | Colo-rectal Cancer | Triple-negative Breast Cancer | Head and Neck Cancer Squamous Cell Carcinoma

United States, Belgium, United Kingdom
ADC Therapeutics S.A.

Completed

Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

Refractory Hodgkin Lymphoma | Relapsed Hodgkin Lymphoma

United States, Spain, United Kingdom, Poland, Belgium, Hungary, Germany, France, Italy, Czechia, Canada
Eurofarma Laboratorios S.A.

Withdrawn

Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil (BENCOX)

Third Molar Extraction

Brazil
ADC Therapeutics S.A.

Terminated

Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma

Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma

United States, Spain, United Kingdom, France, Italy, Belgium
Oryzon Genomics S.A.

Completed

Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

Borderline Personality Disorder

Spain, Serbia, United States, Germany, Bulgaria
ADC Therapeutics S.A.

Terminated

Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma (LOTIS-6)

Relapsed Follicular Lymphoma | Refractory Follicular Lymphoma

United States, Belgium, Hungary, Israel, Spain, Switzerland, Poland, France, United Kingdom, Italy
ADC Therapeutics S.A.

Completed

Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (LOTIS-2)

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-Cell Lymphoma Refractory

United States, United Kingdom, Italy, Switzerland
Inmunova S.A.
Exeltis

Terminated

Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS

Hemolytic-Uremic Syndrome | Pediatric Kidney Disease | Bloody Diarrhea | STEC, Unspecified

Argentina
Apsen Farmaceutica S.A.

Completed

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain (APS003/2020)

Osteoarthritis

Brazil
Aquilon Pharmaceuticals S.A.

Completed

Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics (BOREAS)

Asthma

Belgium
Apsen Farmaceutica S.A.

Completed

Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions

Healthy Volunteers

Brazil
Eurofarma Laboratorios S.A.

Completed

Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee (Artico)

Osteoarthritis of the Knee

Brazil
Arafarma Group, S.A.

Completed

Effects of a Food Supplement on Quality of Life in Patients With Chronic Obstructive Pulmonary Disease. (EPOCAT)

Chronic Obstructive Pulmonary Disease

Spain
Tilman S.A.
Artialis

Completed

Covid-19, Hospitalized, PatIents, Nasafytol

Coronavirus Infection

Belgium
Eurofarma Laboratorios S.A.

Terminated

Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema

Congestive Heart Failure

Brazil
Janssen-Cilag, S.A.

Completed

Treatment Resistant Depression in America Latina (TRAL)

Depressive Disorder, Treatment-Resistant

Brazil, Argentina, Mexico, Colombia
Bone Therapeutics S.A

Completed

A Study on Visco-antalgic Intra-articular Administration in Symptomatic Knee Osteoarthritis

Knee Osteoarthritis
Barbara Jakše s.p.

Completed

WFPB Lifestyle and Muscle Mass Preservation (WFPBmuscle)

Body Weight | Body Weight Changes | Body Image | Muscle Loss

Slovenia
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

Bioequivalence

Chile
Rhein 83 Srl

Completed

Attachment Systems for Implant Overdenture

Dental Implants | Dental Prosthesis Failure

Italy
Bone Therapeutics S.A

Completed

Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion

Degenerative Disc Disease

Belgium
Genesis Pharma S.A.

Completed

Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece (ABReast)

Metastatic Breast Cancer

Greece
Ferrer Internacional S.A.

Completed

Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting

Agitation

Spain
OASIS Diagnostics S.A.

Completed

Impedance Spectroscopy for Obstetric Anal Sphincter Injuries Detection

Obstetric Complication | Delivery Complication | Obstetric Anal Sphincter Injury

Poland
Bone Therapeutics S.A

Completed

A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones (mRUSTUS)

Bone Fracture | Validation Studies | Fracture Healing | X-Ray | Delayed Union Fracture | CT-scan

Germany
ADC Therapeutics S.A.

Terminated

Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors

Advanced Solid Tumors

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

Bioequivalence

Chile

Clinical Trials Sponsored by NTShub, S.L.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations